Terminology Service for NFDI4Health
All individuals in LOINC
| Label | Id | Description |
|---|---|---|
| 14-3-3 protein | Cerebral spinal fluid | Serology - non-micro | LP402562-5 | |
| 14-3-3 protein | Tissue and Smears | Serology - non-micro | LP402563-3 | |
| 14-3-3 protein IB Ql (CSF) | 51833-2 | |
| 14-3-3 protein:PrThr:Pt:Tiss:Ord:Probe.amp.tar | 91065-3 | |
| 14-8-14-8 | LA28065-3 | |
| 14-Hydroxyclarithromycin | MTHU052678 | |
| 14-Hydroxyclarithromycin | LP200332-7 | |
| 14-Hydroxyclarithromycin | DBS | Drug toxicology | LP388944-3 | |
| 14-Hydroxyclarithromycin | Serum or Plasma | Drug toxicology | LP388945-0 | |
| 14-Hydroxyclarithromycin:MCnc:Pt:Bld.dot:Qn | 80607-5 | |
| 14-Hydroxyclarithromycin:MCnc:Pt:Ser/Plas:Qn | 80606-7 | |
| 14-day scheduled assessment | LA10895-3 | |
| 140 minutes | LA31411-4 | |
| 14th specimen | LP99549-5 | |
| 14th specimen post XXX challenge | LP20474-0 | |
| 15 | LA14561-7 | |
| 15 - 24 years old | LA14237-4 | |
| 15 Beta, 17 Alpha-Dihydroxypregnanolone | LP36716-6 | |
| 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine | MTHU027510 | |
| 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine | LP284670-9 |